Epstein-Barr virus nuclear antigen 3 (EBNA3) proteins regulate EBNA2 binding to distinct RBPJ genomic sites

Journal of Virology

Volumn 90, Issue 6, 2016, Pages 2906-2919

  Wang, Anqi ^a   Welch, Rene ^b   Zhao, Bo ^c   Ta, Tram ^b   Keleş, Sündüz ^a,b   Johannsen, Eric ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 2; EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 3A PROTEIN; EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 3B PROTEIN; EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 3C PROTEIN; INTERFERON REGULATORY FACTOR 4; RECOMBINATION SIGNAL BINDING PROTEIN J KAPPA PROTEIN; UNCLASSIFIED DRUG; EBNA-2 PROTEIN, HUMAN HERPESVIRUS 4; EBNA-3A ANTIGEN; EBNA-3B ANTIGEN; EBNA-3C, EPSTEIN-BARR VIRUS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE BINDING PROTEIN; PROTEIN BINDING; RBPJ PROTEIN, HUMAN; VIRAL PROTEIN;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; BIOLOGICAL MODEL; CELL LINE; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; HIGH THROUGHPUT SEQUENCING; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY; VIRUS CELL TRANSFORMATION; VIRUS LATENCY;

CELL LINE; CELL TRANSFORMATION, VIRAL; CHROMATIN IMMUNOPRECIPITATION; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION; HERPESVIRUS 4, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; MODELS, BIOLOGICAL; PROTEIN BINDING; VIRAL PROTEINS; VIRUS LATENCY;

EID: 84961164811     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02737-15     Document Type: Article

References (61)

1. Johannsen E, Kaye K. 2015. Epstein-Barr virus (infectious mononucleosis, Epstein-Barr virus-associated malignant diseases, and other diseases), p 1754-1771. In Bennett J, Dolin R, BlaserM(ed), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, vol 2. Elsevier Saunders, Philadelphia, PA.
2. Longnecker R, Kieff E, Cohen J. 2013. Epstein-Barr virus, p 1898-1959. In Knipe D, Howley P, Cohen J, Griffin D, Lamb R, Martin M, Racaniello V, Roizman B (ed), Fields virology, 6th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
3. Grossman SR, Johannsen E, Tong X, Yalamanchili R, Kieff E. 1994. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proc Natl Acad SciUSA91:7568-7572. http://dx.doi.org/10.1073/pnas.91.16.7568.
4. Henkel T, Ling PD, Hayward SD, Peterson MG. 1994. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signalbinding protein J kappa. Science 265:92-95. http://dx.doi.org/10.1126/science.8016657.
5. Kaiser C, Laux G, Eick D, Jochner N, Bornkamm GW, Kempkes B. 1999. The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2. J Virol 73:4481-4484.
6. Kempkes B, Spitkovsky D, Jansen-Durr P, Ellwart JW, Kremmer E, Delecluse HJ, Rottenberger C, Bornkamm GW, Hammerschmidt W. 1995. B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J 14:88-96.
7. Wang F, Tsang SF, Kurilla MG, Cohen JI, Kieff E. 1990. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J Virol 64:3407-3416.
8. Woisetschlaeger M, Jin XW, Yandava CN, Furmanski LA, Strominger JL, Speck SH. 1991. Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection. Proc Natl Acad Sci U S A 88:3942-3946. http://dx.doi.org/10.1073/pnas.88.9.3942.
9. Rowe M, Raithatha S, Shannon-Lowe C. 2014. Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions. J Virol 88:12065-12076. http://dx.doi.org/10.1128/JVI.01431-14.
10. Strobl LJ, Hofelmayr H, Marschall G, Brielmeier M, Bornkamm GW, Zimber-Strobl U. 2000. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. J Virol 74:1727-1735. http://dx.doi.org/10.1128/JVI.74.4.1727-1735.2000.
11. Hofelmayr H, Strobl LJ, Marschall G, Bornkamm GW, Zimber-Strobl U. 2001. Activated Notch1 can transiently substitute for EBNA2 in the maintenance of proliferation of LMP1-expressing immortalized B cells. J Virol 75:2033-2040. http://dx.doi.org/10.1128/JVI.75.5.2033-2040.2001.
12. Tzellos S, Correia PB, Karstegl CE, Cancian L, Cano-Flanagan J, Mc-Clellan MJ, West MJ, Farrell PJ. 2014. A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus type 1 EBNA-2. J Virol 88:8743-8753. http://dx.doi.org/10.1128/JVI.01000-14.
13. Robertson ES, Lin J, Kieff E. 1996. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ( kappa). J Virol 70:3068-3074.
14. Zhao B, Marshall DR, Sample CE. 1996. A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa. J Virol 70:4228-4236.
15. Calderwood MA, Lee S, Holthaus AM, Blacklow SC, Kieff E, Johannsen E. 2011. Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth. Virology 414:19-25. http://dx.doi.org/10.1016/j.virol.2011.02.018.
16. Cooper A, Johannsen E, Maruo S, Cahir-McFarland E, Illanes D, Davidson D, Kieff E. 2003. EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth. J Virol 77:999-1010. http://dx.doi.org/10.1128/JVI.77.2.999-1010.2003.
17. Dalbies-Tran R, Stigger-Rosser E, Dotson T, Sample CE. 2001. Amino acids of Epstein-Barr virus nuclear antigen 3A essential for repression of jkappa-mediated transcription and their evolutionary conservation. J Virol 75:90-99. http://dx.doi.org/10.1128/JVI.75.1.90-99.2001.
18. Waltzer L, Perricaudet M, Sergeant A, Manet E. 1996. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA. J Virol 70:5909-5915.
19. Anderton E, Yee J, Smith P, Crook T, White RE, Allday MJ. 2008. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene 27:421-433. http://dx.doi.org/10.1038/sj.onc.1210668.
20. Chen A, Zhao B, Kieff E, Aster JC, Wang F. 2006. EBNA-3B-and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines. J Virol 80:10139-10150. http://dx.doi.org/10.1128/JVI.00854-06.
21. Hertle ML, Popp C, Petermann S, Maier S, Kremmer E, Lang R, Mages J, Kempkes B. 2009. Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes. PLoS Pathog 5:e1000506. http://dx.doi.org/10.1371/journal.ppat.1000506.
22. Maruo S, Zhao B, Johannsen E, Kieff E, Zou J, Takada K. 2011. Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression. Proc Natl Acad Sci U S A 108:1919-1924. http://dx.doi.org/10.1073/pnas.1019 599108.
23. Skalska L, White RE, Parker GA, Turro E, Sinclair AJ, Paschos K, Allday MJ. 2013. Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines. PLoS Pathog 9:e1003187. http://dx.doi.org/10.1371/journal.ppat.1003187.
24. White RE, Groves IJ, Turro E, Yee J, Kremmer E, Allday MJ. 2010. Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification. PLoS One 5:e13979. http://dx.doi.org/10.1371/journal.pone.0013979.
25. Zhao B, Mar JC, Maruo S, Lee S, Gewurz BE, Johannsen E, Holton K, Rubio R, Takada K, Quackenbush J, Kieff E. 2011. Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines. Proc Natl Acad Sci U S A 108:337-342. http://dx.doi.org/10.1073/pnas.1017419108.
26. Bazot Q, Paschos K, Skalska L, Kalchschmidt JS, Parker GA, Allday MJ. 2015. Epstein-Barr virus proteins EBNA3A and EBNA3C together induce expression of the oncogenic microRNA cluster miR-221/miR-222 and ablate expression of its target p57KIP2. PLoS Pathog 11:e1005031. http://dx.doi.org/10.1371/journal.ppat.1005031.
27. Tursiella ML, Bowman ER, Wanzeck KC, Throm RE, Liao J, Zhu J, Sample CE. 2014. Epstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1. PLoS Pathog 10:e1004415. http://dx.doi.org/10.1371/journal.ppat.1004415.
28. Nikitin PA, Yan CM, Forte E, Bocedi A, Tourigny JP, White RE, Allday MJ, Patel A, Dave SS, Kim W, Hu K, Guo J, Tainter D, Rusyn E, Luftig MA. 2010. An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells. Cell Host Microbe 8:510-522. http://dx.doi.org/10.1016/j.chom.2010.11.004.
29. Paschos K, Parker GA, Watanatanasup E, White RE, Allday MJ. 2012. BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV. Nucleic Acids Res 40:7233-7246. http://dx.doi.org/10.1093/nar/gks391.
30. Lee S, Sakakibara S, Maruo S, Zhao B, Calderwood MA, Holthaus AM, Lai CY, Takada K, Kieff E, Johannsen E. 2009. Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1. J Virol 83:12368-12377. http://dx.doi.org/10.1128/JVI.01403-09.
31. Maruo S, Johannsen E, Illanes D, Cooper A, Zhao B, Kieff E. 2005. Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-Jkappa/CBF1 is critical. J Virol 79:10171-10179. http://dx.doi.org/10.1128/JVI.79.16.10171-10179.2005.
32. Maruo S, Wu Y, Ito T, Kanda T, Kieff ED, Takada K. 2009. Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth. Proc Natl Acad Sci U S A 106:4419-4424. http://dx.doi.org/10.1073/pnas.0813134106.
33. McClellan MJ, Wood CD, Ojeniyi O, Cooper TJ, Kanhere A, Arvey A, Webb HM, Palermo RD, Harth-Hertle ML, Kempkes B, Jenner RG, West MJ. 2013. Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming. PLoS Pathog 9:e1003636. http://dx.doi.org/10.1371/journal.ppat.1003636.
34. Ohashi M, Holthaus AM, Calderwood MA, Lai CY, Krastins B, Sarracino D, Johannsen E. 2015. The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth. PLoS Pathog 11: e1004822. http://dx.doi.org/10.1371/journal.ppat.1004822.
35. Jiang S, Willox B, Zhou H, Holthaus AM, Wang A, Shi TT, Maruo S, Kharchenko PV, Johannsen EC, Kieff E, Zhao B. 2014. Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A. Proc Natl Acad Sci U S A 111:421-426. http://dx.doi.org/10.1073/pnas.1321704111.
36. Sciammas R, Shaffer AL, Schatz JH, Zhao H, Staudt LM, Singh H. 2006. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 25:225-236. http://dx.doi.org/10.1016/j.immuni.2006.07.009.
37. Maruo S, Johannsen E, Illanes D, Cooper A, Kieff E. 2003. Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth. J Virol 77:10437-10447. http://dx.doi.org/10.1128/JVI.77.19.10437-10447.2003.
38. Menezes J, Leibold W, Klein G, Clements G. 1975. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Biomedicine 22:276-284.
39. Lebkowski JS, Clancy S, Calos MP. 1985. Simian virus 40 replication in adenovirus-transformed human cells antagonizes gene expression. Nature 317:169-171. http://dx.doi.org/10.1038/317169a0.
40. Maunders MJ, Petti L, Rowe M. 1994. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody. J Gen Virol 75:769-778. http://dx.doi.org/10.1099/0022-1317-75-4-769.
41. Rozenblatt-Rosen O, Deo RC, Padi M, Adelmant G, Calderwood MA, Rolland T, Grace M, Dricot A, Askenazi M, Tavares M, Pevzner SJ, Abderazzaq F, Byrdsong D, Carvunis AR, Chen AA, Cheng J, Correll M, Duarte M, Fan C, Feltkamp MC, Ficarro SB, Franchi R, Garg BK, Gulbahce N, Hao T, Holthaus AM, James R, Korkhin A, Litovchick L, Mar JC, Pak TR, Rabello S, Rubio R, Shen Y, Singh S, Spangle JM, Tasan M, Wanamaker S, Webber JT, Roecklein-Canfield J, Johannsen E, Barabasi AL, Beroukhim R, Kieff E, Cusick ME, Hill DE, Munger K, Marto JA, Quackenbush J, Roth FP, DeCaprio JA, Vidal M. 2012. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature 487:491-495. http://dx.doi.org/10.1038/nature11288.
42. Zhao B, Zou J, Wang H, Johannsen E, Peng CW, Quackenbush J, Mar JC, Morton CC, Freedman ML, Blacklow SC, Aster JC, Bernstein BE, Kieff E. 2011. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc Natl Acad Sci U S A 108:14902-14907. http://dx.doi.org/10.1073/pnas.1108892108.
43. Kuan PF, Chung DJ, Pan GJ, Thomson JA, Stewart R, Keles S. 2011. A statistical framework for the analysis of ChIP-Seq data. J Am Stat Assoc 106:891-903. http://dx.doi.org/10.1198/jasa.2011.ap09706.
44. Machanick P, Bailey TL. 2011. MEME-ChIP: motif analysis of large DNA datasets. Bioinformatics 27:1696-1697. http://dx.doi.org/10.1093/bioin formatics/btr189.
45. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25. http://dx.doi.org/10.1186/gb-2009-10-3-r25.
46. Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B, Garg K, John S, Sandstrom R, Bates D, Boatman L, Canfield TK, Diegel M, Dunn D, Ebersol AK, Frum T, Giste E, Johnson AK, Johnson EM, Kutyavin T, Lajoie B, Lee BK, Lee K, London D, Lotakis D, Neph S, Neri F, Nguyen ED, Qu H, Reynolds AP, Roach V, Safi A, Sanchez ME, Sanyal A, Shafer A, Simon JM, Song L, Vong S, Weaver M, Yan Y, Zhang Z, Lenhard B, Tewari M, Dorschner MO, Hansen RS, Navas PA, Stamatoyannopoulos G, Iyer VR, Lieb JD, Sunyaev SR, Akey JM, Sabo PJ, Kaul R, Furey TS, Dekker J, Crawford GE, Stamatoyannopoulos JA. 2012. The accessible chromatin landscape of the human genome. Nature 489:75-82. http://dx.doi.org/10.1038/nature11232.
47. Natarajan A, Yardimci GG, Sheffield NC, Crawford GE, Ohler U. 2012. Predicting cell-type-specific gene expression from regions of open chromatin. Genome Res 22:1711-1722. http://dx.doi.org/10.1101/gr.135129.111.
48. Schneider R, Grosschedl R. 2007. Dynamics and interplay of nuclear architecture, genome organization, and gene expression. Genes Dev 21: 3027-3043. http://dx.doi.org/10.1101/gad.1604607.
49. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang X, Wang L, Issner R, Coyne M, Ku M, Durham T, Kellis M, Bernstein BE. 2011. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473:43-49. http://dx.doi.org/10.1038/nature09906.
50. Johannsen E, Miller CL, Grossman SR, Kieff E. 1996. EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes. J Virol 70:4179-4183.
51. Schmidt SC, Jiang S, Zhou H, Willox B, Holthaus AM, Kharchenko PV, Johannsen EC, Kieff E, Zhao B. 2015. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered toDNA through BATF complexes. Proc Natl Acad Sci U S A 112:554-559. http://dx.doi.org/10.1073/pnas.1422580112.
52. McClellan MJ, Khasnis S, Wood CD, Palermo RD, Schlick SN, Kanhere AS, Jenner RG, West MJ. 2012. Downregulation of integrin receptorsignaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and-distal binding elements. J Virol 86:5165-5178. http://dx.doi.org/10.1128/JVI.07161-11.
53. Harth-Hertle ML, Scholz BA, Erhard F, Glaser LV, Dolken L, Zimmer R, Kempkes B. 2013. Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9. PLoS Pathog 9:e1003638. http://dx.doi.org/10.1371/journal.ppat.1003638.
54. Xu D, Zhao L, Del Valle L, Miklossy J, Zhang L. 2008. Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes. J Virol 82:6251-6258. http://dx.doi.org/10.1128/JVI.00163-08.
55. Banerjee S, Lu J, Cai Q, Saha A, Jha HC, Dzeng RK, Robertson ES. 2013. The EBV latent antigen 3C inhibits apoptosis through targeted regulation of interferon regulatory factors 4 and 8. PLoS Pathog 9:e1003314. http://dx.doi.org/10.1371/journal.ppat.1003314.
56. De Silva NS, Simonetti G, Heise N, Klein U. 2012. The diverse roles of IRF4 in late germinal center B-cell differentiation. Immunol Rev 247:73-92. http://dx.doi.org/10.1111/j.1600-065X.2012.01113.x.
57. Lenz G, Staudt LM. 2010. Aggressive lymphomas. N Engl J Med 362: 1417-1429. http://dx.doi.org/10.1056/NEJMra0807082.
58. Wang L, Yao ZQ, Moorman JP, Xu Y, Ning S. 2014. Gene expression profiling identifies IRF4-associated molecular signatures in hematological malignancies. PLoS One 9:e106788. http://dx.doi.org/10.1371/journal.pone.0106788.
59. Simonetti G, Carette A, Silva K, Wang H, De Silva NS, Heise N, Siebel CW, Shlomchik MJ, Klein U. 2013. IRF4 controls the positioning of mature B cells in the lymphoid microenvironments by regulating NOTCH2 expression and activity. J Exp Med 210:2887-2902. http://dx.doi.org/10.1084/jem.20131026.
60. Martin F, Kearney JF. 2000. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory." Immunol Rev 175:70-79.
61. Tanigaki K, Han H, Yamamoto N, Tashiro K, Ikegawa M, Kuroda K, Suzuki A, Nakano T, Honjo T. 2002. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat Immunol 3:443-450.